13F reference period
n/a
Security Snapshot
Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX) Institutional Ownership
CUSIP: 74907L300
13F Institutional Holders and Ownership History from Q3 2023 to Q2 2025
Institutions Reporting
Shares (Excl. Options)
n/a
Price
$0.26
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S
- Symbol
- QNRX on Nasdaq
- Shares outstanding
- 9,352,472
- SEC-reported price per share
- $0.26
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- QNRX - Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S is tracked under CUSIP 74907L300.
- 13F reference-period holder data is not available.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder data for the Q2 2026 reference period is not available.
- Available periods remain in the history table; they do not substitute for the headline period.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
74907L300
13F reference period
n/a
13F holders
13D/G owners
3
CIK / CUSIP context first
QNRX full holder history
Quoin Pharmaceuticals Ltd. SEC filings
Quoin Pharmaceuticals Ltd. company facts
Quoin Pharmaceuticals Ltd. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74907L300:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
QNRX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Carter Denise P. | 4.9% | -29% | $244,202 | +$82,374 | 939,238 | +51% | Denise Carter | 27 Jan 2025 |
| Myers Michael | 4.9% | -29% | $244,200 | +$82,331 | 939,230 | +51% | Michael Myers | 27 Jan 2025 |
| ARMISTICE CAPITAL, LLC | 10% | $242,921 | 934,312 | Armistice Capital, LLC | 31 Dec 2024 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
8
Headline period
n/a
Rows shown
1-8 of 8
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q2 | 0 | $0 | -$90,191 | $0.26 | 0 |
| 2025 Q1 | 401,522 | $90,191 | -$858,956 | $0.22 | 9 |
| 2024 Q4 | 1,546,454 | $1,006,247 | +$902,262 | $0.65 | 14 |
| 2024 Q3 | 165,081 | $82,231 | -$38,728 | $0.49 | 7 |
| 2024 Q2 | 220,073 | $127,678 | -$10,488 | $0.58 | 10 |
| 2024 Q1 | 194,151 | $183,220 | +$81,697 | $0.95 | 8 |
| 2023 Q4 | 22,047 | $105,643 | +$97,753 | $4.82 | 3 |
| 2023 Q3 | 1,735 | $7,212 | +$7,212 | $4.15 | 3 |